Mothering over meds: Docs say common treatment for opioid-exposed babies isn’t necessary

On learning last year she was pregnant with her second child, Cailyn Morreale was overcome with fear and trepidation.

AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq

Rinvoq is one of the top revenue-generating therapies for AbbVie, raking in approximately $4bn in sales last year, per the company’s financials. Image Credit: Skorzewiak

July 15, 2024

Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023 – Pharmaceutical Technology

Share this article Figure 1: Top 20 global biopharmaceutical companies, by market cap, as of 31 December 2023. Source: GlobalData, Pharma Intelligence Center, Stock Exchanges,

March 1, 2024

How Cannabis Laws and Mental Health Prescription Drugs Are Linked

In this video interview, Ashley Bradford, PhD, of the Georgia Institute of Technology School of Public Policy in Atlanta, discusses her new paper in JAMA

September 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.